FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35019211000001103: Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Jan 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106078201000001114 Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106078301000001117 Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Is a Naratriptan 2.5mg tablets 6 tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has AMP Naratriptan 2.5mg tablets (Creo Pharma Ltd) true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier 1
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has presentation strength numerator value 2.5 false Inferred relationship Existential restriction modifier 1
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has excipient Polyoxyl castor oil false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has specific active ingredient Naratriptan hydrochloride true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Creo Pharma Ltd) 6 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start